(Q80097758)
Statements
Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients (English)
Stephen A Schey
Ping Wu
Muralikrishan Srikanth
Karen J Phekoo
Faith E Davies